Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Beyond Radiation and Chemotherapy
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?
Presenters
Facebook Comments